Related Experiment Video
Updated: Dec 28, 2025

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
AJAP1 affects behavioral changes and GABABR1 level in epileptic mice
Mingli Zhang1, Xueying Zhou2, Wei Jiang3
1Department of Neurology, Qilu Hospital of Shandong University and Brain Science Research Institute, Shandong University, China; Department of Intensive Care Unit, Jinan Central Hospital Affiliated to Shandong University, China.
Adherens junction-associated protein-1 (AJAP1) is downregulated in epilepsy. Increasing AJAP1 expression reduces seizures, suggesting it may be a new target for epilepsy treatment.
Area of Science:
- Neuroscience
- Molecular Biology
- Pathology
Background:
- Adherens junction-associated protein-1 (AJAP1), also known as SHREW1, is implicated in tumor suppression.
- Recent findings link AJAP1 to the GABAB receptor subunit 1, suggesting a potential role in neurological functions.
- The precise role of AJAP1 in epilepsy remains largely unexplored.
Purpose of the Study:
- To investigate the expression and localization of AJAP1 in temporal lobe epilepsy (TLE) patients and a kainic acid (KA)-induced epilepsy model.
- To determine the functional impact of AJAP1 modulation on seizure activity in an epilepsy model.
Main Methods:
- Immunofluorescence and Western blot analyses were used to examine AJAP1 expression and location in TLE patients and KA-induced epilepsy models.
- Lentiviral vectors were employed to overexpress and inhibit AJAP1 in KA-induced epilepsy models.
- Seizure frequency and incidence rates were monitored in response to AJAP1 modulation.
Main Results:
- AJAP1 was primarily detected in neurons.
- AJAP1 expression was significantly downregulated in the neocortex of TLE patients and in the hippocampus and neocortex of epileptic animal models.
- Overexpression of AJAP1 reduced spontaneous seizure frequency, while inhibition of AJAP1 increased seizure incidence.
Conclusions:
- AJAP1 is expressed in neurons and its downregulation is associated with epilepsy.
- Modulating AJAP1 levels affects seizure activity, indicating its involvement in epilepsy pathogenesis.
- AJAP1 represents a potential novel therapeutic target for epilepsy.
Related Concept Videos
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Glutamate Antagonists

